These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 35326497)
1. Cardiac Ischemia On-a-Chip: Antiarrhythmic Effect of Levosimendan on Ischemic Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Gaballah M; Penttinen K; Kreutzer J; Mäki AJ; Kallio P; Aalto-Setälä K Cells; 2022 Mar; 11(6):. PubMed ID: 35326497 [TBL] [Abstract][Full Text] [Related]
2. In silico study of the mechanisms of hypoxia and contractile dysfunction during ischemia and reperfusion of hiPSC cardiomyocytes. Forouzandehmehr M; Paci M; Hyttinen J; Koivumäki JT Dis Model Mech; 2024 Apr; 17(4):. PubMed ID: 38516812 [TBL] [Abstract][Full Text] [Related]
3. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications. Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518 [TBL] [Abstract][Full Text] [Related]
4. Modeling of Shah D; Virtanen L; Prajapati C; Kiamehr M; Gullmets J; West G; Kreutzer J; Pekkanen-Mattila M; Heliö T; Kallio P; Taimen P; Aalto-Setälä K Cells; 2019 Jun; 8(6):. PubMed ID: 31208058 [TBL] [Abstract][Full Text] [Related]
5. Advancing Human iPSC-Derived Cardiomyocyte Hypoxia Resistance for Cardiac Regenerative Therapies through a Systematic Assessment of In Vitro Conditioning. Snyder CA; Dwyer KD; Coulombe KLK Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273573 [TBL] [Abstract][Full Text] [Related]
6. Danshen-Enhanced Cardioprotective Effect of Cardioplegia on Ischemia Reperfusion Injury in a Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Model. Wei W; Liu Y; Zhang Q; Wang Y; Zhang X; Zhang H Artif Organs; 2017 May; 41(5):452-460. PubMed ID: 27925238 [TBL] [Abstract][Full Text] [Related]
7. Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research. Andrysiak K; Stępniewski J; Dulak J Pflugers Arch; 2021 Jul; 473(7):1061-1085. PubMed ID: 33629131 [TBL] [Abstract][Full Text] [Related]
8. In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes. Davis J; Chouman A; Creech J; Monteiro da Rocha A; Ponce-Balbuena D; Jimenez Vazquez EN; Nichols R; Lozhkin A; Madamanchi NR; Campbell KF; Herron TJ JCI Insight; 2021 May; 6(10):. PubMed ID: 33878037 [TBL] [Abstract][Full Text] [Related]
9. Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype. Yokoyama J; Miyagawa S; Akagi T; Akashi M; Sawa Y PLoS One; 2021; 16(3):e0245571. PubMed ID: 33720933 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch. Khan M; Xu Y; Hua S; Johnson J; Belevych A; Janssen PM; Gyorke S; Guan J; Angelos MG PLoS One; 2015; 10(5):e0126338. PubMed ID: 25993466 [TBL] [Abstract][Full Text] [Related]
11. Exosomal Preconditioning of Human iPSC-Derived Cardiomyocytes Beneficially Alters Cardiac Electrophysiology and Micro RNA Expression. Røsand Ø; Wang J; Scrimgeour N; Marwarha G; Høydal MA Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126028 [TBL] [Abstract][Full Text] [Related]
12. Human induced pluripotent stem cell-based platform for modeling cardiac ischemia. Häkli M; Kreutzer J; Mäki AJ; Välimäki H; Lappi H; Huhtala H; Kallio P; Aalto-Setälä K; Pekkanen-Mattila M Sci Rep; 2021 Feb; 11(1):4153. PubMed ID: 33603154 [TBL] [Abstract][Full Text] [Related]
13. TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT. Devalla HD; Gélinas R; Aburawi EH; Beqqali A; Goyette P; Freund C; Chaix MA; Tadros R; Jiang H; Le Béchec A; Monshouwer-Kloots JJ; Zwetsloot T; Kosmidis G; Latour F; Alikashani A; Hoekstra M; Schlaepfer J; Mummery CL; Stevenson B; Kutalik Z; de Vries AA; Rivard L; Wilde AA; Talajic M; Verkerk AO; Al-Gazali L; Rioux JD; Bhuiyan ZA; Passier R EMBO Mol Med; 2016 Dec; 8(12):1390-1408. PubMed ID: 27861123 [TBL] [Abstract][Full Text] [Related]
14. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity. Yang X; Papoian T J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688 [TBL] [Abstract][Full Text] [Related]
15. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802 [TBL] [Abstract][Full Text] [Related]
16. Mutation-specific differences in arrhythmias and drug responses in CPVT patients: simultaneous patch clamp and video imaging of iPSC derived cardiomyocytes. Pölönen RP; Swan H; Aalto-Setälä K Mol Biol Rep; 2020 Feb; 47(2):1067-1077. PubMed ID: 31786768 [TBL] [Abstract][Full Text] [Related]
17. Regulation of Ca Fernández-Morales JC; Hua W; Yao Y; Morad M Cell Calcium; 2019 Mar; 78():1-14. PubMed ID: 30579812 [TBL] [Abstract][Full Text] [Related]
18. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle. Zhu W; Zhao M; Mattapally S; Chen S; Zhang J Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036 [TBL] [Abstract][Full Text] [Related]
19. Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Gong Y; Yang L; Tang J; Zheng J; Witman N; Jakob P; Tan Y; Liu M; Chen Y; Wang H; Fu W; Wang W Cardiovasc Toxicol; 2022 Feb; 22(2):141-151. PubMed ID: 34817810 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic variability in LQT3 human induced pluripotent stem cell-derived cardiomyocytes and their response to antiarrhythmic pharmacologic therapy: An in silico approach. Paci M; Passini E; Severi S; Hyttinen J; Rodriguez B Heart Rhythm; 2017 Nov; 14(11):1704-1712. PubMed ID: 28756098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]